R. Bruno Bossio

Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

D. Centonze, M. Rovaris, C. Pozzilli, 2020, Clinical Drug Investigation.

Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data

Alessia Sarica, Valeria Saccà, Fabiana Novellino, 2018, Brain Imaging and Behavior.

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study

D. Centonze, M. Rovaris, M. Zaffaroni, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study

M. Russo, M. Zaffaroni, C. Gasperini, 2020, Neurological Sciences.

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

D. Centonze, M. Rovaris, C. Pozzilli, 2016, Journal of Neurology, Neurosurgery & Psychiatry.